Gadd45 stress sensors in malignancy and leukemia

Critical Reviews in Oncogenesis

Volumn 16, Issue 1-2, 2011, Pages 129-140

  Liebermann, Dan A ^a,b   Tront, Jennifer S ^a   Sha, Xiogen ^b   Mukherjee, Ksushiki ^b   Alisha Mohamed Hadley, ^a   Hoffman, Barbara ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Cancer; Gadd45; Leukemia

Indexed keywords

BCR ABL PROTEIN; CYTOKINE; DAUNORUBICIN; DNA; ETOPOSIDE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; K RAS PROTEIN; MESYLIC ACID METHYL ESTER; MYC PROTEIN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; BREAST CANCER; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; COLON CANCER; CYTOKINE RELEASE; DNA METHYLATION; DNA REPAIR; ENVIRONMENTAL STRESS; GENE EXPRESSION; HODGKIN DISEASE; IRRADIATION; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; ONCOGENE K RAS; OVARY CANCER; PANCREAS CANCER; PHYSIOLOGICAL STRESS; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SOLID TUMOR; STOMACH CANCER; TUMOR GROWTH; ULTRAVIOLET RADIATION;

EID: 83255187529     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v16.i1-2.120     Document Type: Article

References (79)

1. Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, Kastan MB, Fornace AJ Jr. Characterization of human Gadd45, a p53-regulated protein. J Biol Chem. 1994:269:32672-7.
2. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol. 1994;14:2361-71.
3. Liebermann DA, Hoffman B. MyD genes in negative growth control. Oncogene. 1998;17: 3319-30.
4. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA. CR6:A third member in the MyD118 & Gadd45 gene family which functions in negative growth control. Oncogene. 1999;18:4899-907.
5. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Sequence and expression of a cDNA encoding MyD118: A novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene. 1991;6:165-7.
6. Beadling C, Johnson KW, Smith KA. Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci USA. 1993;90:2719-23.
7. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr. Genomic instability in Gadd45adeficientmice. Nat Genet. 1999;23:176-84.
8. Gupta M, Gupta S, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebernmann DA. Hematopoietic cells from Gadd45a and Gadd45b deficient mice are sensitized to genotoxic-stress Induced apoptosis. Oncogene. 2005;24:7170-9.
9. Gupta S, Gupta M, Hoffman B, Liebermann DA. Hematopoietic cells from gadd45a deficient and gadd45b deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation, and inflammation. Oncogene. 2006;25:5537-46.
10. Selvakumaran M, Lin HK, Tjin Tham Sjin R, Reed J, Liebermann DA, Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2modulate transforming growth factor b1-induced apoptosis of myeloid leukemia cells. MolCell Biol. 1994;14:2352-60.
11. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Bottinger EP, Roberts AB. TGF-beta-induced apoptosis is mediated by Smaddependentexpression of GADD45B through p38 activation. J Biol Chem. 2003;278:43001-7.
12. Liebermann DA, Hoffman B. Gadd45 in stress signaling. J Mol Signal. 2008;3:15.
13. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornace AJ Jr. AntisenseGADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene. 1996;13:2255-63.
14. Vairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA. Characterization of MyD118, Gadd45, and PCNA interacting domains: PCNA impedes MyD/Gadd mediatednegative growth control. J Biol Chem. 2000; 275:16810-9.
15. Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA, Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA. Interaction of CR6 (GADD45gamma) with proliferating cell nuclear antigen impedes negative growth control. J Biol Chem. 2001;276:2766-74.
16. Liebermann DA, Hoffman B. Gadd45 in the response of hematopoietic cells togenotoxic stress. Blood Cells Mol Dis. 2007;39:329-35.
17. Barreto G, Schäfer A, Marhold J, Stach D, Swaminathan SK, Handa V, Döderlein G, Maltry N, Wu W, Lyko F, Niehrs C. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature. 2007;445, 671-5.
18. Schmitz KM, Schmitt N, Hoffmann-Rohrer U, Schäfer A, Grummt I, Mayer C. TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol Cell. 2009;33:344-53.
19. Engel N, Tront JS, Erinle T, Nguyen N, Latham KE, Sapienza C, Hoffman B, Liebermann DA. Conserved DNA methylation in Gadd45a(-/-) mice. Epigenetics 2009;4:98-9.
20. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, Gadd45. Cell. 2008;135:1201-12.
21. Ma DK, Jang MH, Guo JU, Kitabatake Y, Chang ML, Pow-Anpongkul N, Flavell RA, Lu B, Ming GL, Song H. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science. 2009;323:1074-7.
22. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA. 1999;96:3706-11.
23. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA. GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol. 2002;192:327-38.
24. Fan W, Richter G, Cereseto A, Beadling C, Smith KA. Cytokine response gene 6induces p21 and regulates both cell growth and arrest. Oncogene. 1999;18:6573-82.
25. Miyake Z, Takekawa M, Ge Q, Saito H. Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol. 2007;27:2765-76.
26. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, Nguyen DU, Pham CG, Nelsbach AH, Melis T, De Smaele E, Tang WJ, D'Adamio L, Franzoso G. Gadd45 betamediates the NF-kappa B suppression of JNK signalling by targeting MKK7/ JNKK2. Nat Cell Biol. 2004;6:146-53.
27. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4/MAPKKK. Cell. 1998;95:521-30.
28. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace AJ Jr. Gadd45a protects against UV irradiationinduced skin tumors, and promotesapoptosis and stress signaling via MAPK and p53. Cancer Res. 2002;62:7305-15.
29. Zhu N, Shao Y, Xu L, Yu L, Sun L. Gadd45-alpha and Gadd45-gamma utilize p38 and JNK signaling pathways to induce cell cycle G2/M arrest in Hep-G2 hepatoma cells. Mol Biol Rep. 2009 36:2075-85.
30. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, Liebermann D. Cell signalling: Cell survival and a Gadd45-factor deficiency. Nature. 2003;424:741-2.
31. Tornatore L, Marasco D, Dathan N, Vitale RM, Benedetti E, Papa S, Franzoso G, Ruvo M, Monti SM. Gadd45 beta forms a homodimeric complex that binds tightly to MKK7. J Mol Biol. 2008;378:97-111.
32. Gupta M, Gupta S, Hoffman B, Liebermann DA. Gadd45a and gadd45b protect hematopoietic cells from ultraviolet radiation induced apoptosis via distinct signaling pathways. J Biol Chem. 2006;281:17552-8.
33. Kovalsky O, Lung FD, Roller PP, Fornace AJ Jr. Oligomerization of human Gadd45a protein. J Biol Chem. 2001;276:39330-9.
34. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. Genes involved in senescence and immortalization. Curr Opin Cell Biol. 2000;12:705-9.
35. Drayton S, Peters G. Immortalisation and transformation revisited. Curr Opin Genet Dev. 2002;12: 98-104.
36. Bulavin DV, Kovalsky O, Hollander MC, Fornace AJ Jr. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol Cell Biol. 2003;23:3859-71.
37. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou JR, Libermann TA. NF-kappa B-mediated repression of growth arrest- and DNAdamage- inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci USA. 2004;101:13618-23.
38. Wang W, Huper G, Guo Y, Murphy SK, Olson JA Jr, Marks JR. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene. 2005;24:2705-14.
39. Bahar A, Bicknell JE, Simpson DJ, Clayton RN, Farrell WE. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation. Oncogene. 2004;23:936-44.
40. Sun L, Gong R, Wan B, Huang X, Wu C, Zhang X, Zhao S, Yu L. GADD45g, down-regulated in 65% hepatocellular carcinoma (HCC) from 23 Chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for hepatoma Hep-G2 cell lines. Mol Biol Rep. 2003;30:249-53.
41. Na YK, Lee SM, Hong HS, Kim JB, Park JY, Kim DS. Hypermethylation of growth arrest DNAdamage- inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features. Mol Cells. 2010;30:89-92.
42. Higgs MR, Lerat H, Pawlotsky JM. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res. 2010;70:4901-11.
43. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res. 2005;11:6442-9.
44. Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R. Methylation-mediated repression of GADD45a in prostate cancer and its role as a potential therapeutic target. Cancer Res. 2009;69:1527-35.
45. Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S. Gadd45a is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer. 2006;11:2405-11.
46. Li Y, Qian H, Li X, Wang H, Yu J, Liu Y, Zhang X, Liang X, Fu M, Zhan Q, Lin C. Adenoviralmediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell. J Gene Med. 2009;11:3-13.
47. Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human human pancreatic cancer. Clin Cancer Res. 2002;8:2563-9.
48. Cretu A, Sha X, Tront J, Hoffman B, Liebermann DA. Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Therapy. 2009;7(A):268-76.
49. Tront JS, Hoffman B, Liebermann DA. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of JNK and p38 stress signaling resulting in apoptosis and senescence. Cancer Research. 2006;66:8448-54.
50. Tront JS, Huang Y, Fornace A, Hoffman B, Liebermann DA. Gadd45a promotes or suppresses breast cancer dependent on the oncogenic stress. Cancer Research. 2010;70:9671-81.
51. Hoffman B, Liebermann DA. Gadd45 modulation of intrinsic and extrinsic stress responses in myeloid cells. J Cell Physiol. 2009;218:26-31.
52. Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM. FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells. 2006;24:1174-84.
53. Perugini M, Kok CH, Brown AL, Wilkinson CR, Salerno DG, Young SM, Diakiw SM, Lewis ID, Gonda TJ, D'Andrea RJ. Repression of Gadd45a by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation. Leukemia. 2009;23:729-38.
54. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R. Prognostically useful gene-expression profiles in acutemyeloid leukemia. N Engl J Med. 2004;350:1617-28.
55. Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica. 2005;90:1617-25.
56. Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T, Kitamura T, Hayashi Y, Nosaka T. Dimerization of MLL fusion proteins and FLT3 activationsynergize to induce multiple-lineage leukemogenesis. J Clin Invest. 2005;115:919-29.
57. Ikeda A, Shankar DB, Watanabe M, Tamanoi F, Moore TB, Sakamoto KM. Molecular targets and the treatment of myeloid leukemia. Mol Genet Metabol. 2006;88;216-24.
58. Reimann C, Arola M, Bierings M, Karow A, van den Heuvel-Eibrink MM, Hasle H, Niemeyer CM, Kratz CP. A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia. Leukemia. 2006;20:1637-8.
59. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood. 1994;83:2248-54.
60. Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Res. 2007;67:7139-46.
61. Virchow R. Weisses Blut. Froiep's Notzien. 1845; 36:151.
62. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. J Nat Cancer Inst. 1960;25:85-109.
63. Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA. 1967;58:1468-71.
64. Bernards A, Rubin CM, Westbrook CA, Paskind M, Baltimore D. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol. 1987;7:3231-6.
65. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93-9.
66. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1982;300:765-7.
67. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G. Structural organization of the bcr gene and its role in the Ph' translocation. Nature. 1985;315:758-61.
68. Melo JV. BCR-ABL gene variants. Baillieres Clin Haematol 1997;10:203-22.
69. Tefferi AD, Gilliland DG. Oncogenes in myeloproliferative disorders. Cell Cycle. 2007;6: 550-66.
70. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol. 2006;16:318-30.
71. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ. Cancer therapeutics: targeting the dark side of Myc. Eur J of Cancer. 2005;41:2485-501.
72. Afar DE, Goga A, McLaughlin J, Witte ON, Sawyers CL. Differential complementation of Bcr-Abl point mutants with c-Myc. Science. 1994;264:424-6.
73. Alitalo K, Saksela K, Winqvist R, Alitalo R, Keski-Oja J, Laiho M, Ilvonen M, Knuutila S, de la Chapelle A. Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet. 1985;2:1035-9.
74. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100: 1532-42.
75. Sawyers CL, Callahan W, Witte ON. Dominant negative MYC blocks transformation by ABL oncogenes. Cell. 1992;70:901-910.
76. Müller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Köhler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cel Biol. 2004;24:2890-904.
77. Slovak ML, Ho JP, Pettenati MJ, Khan A, Douer D, Lal S, Traweek ST. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia. Genes Chromosomes Cancer. 1994;9:62-7.
78. Luo H, Li Q, O'Neal J, Kreisel F, Le Beau MM, Tomasson MH. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood. 2005;106:2452-61.
79. Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT, Tomasson MH. Mcl1 haploinsufficiency protects mice from myc-induced acute myeloid leukemia. J Clin Invest. 2010;120: 2109-18.